Induction of cell death and gain-of-function properties of connexin26 mutants predict severity of skin disorders and hearing loss

• Published in: The Journal of biological chemistry Vol. 292; no. 23; pp. 9721 - 9732
• Main Authors: Press, Eric R., Shao, Qing, Kelly, John J., Chin, Katrina, Alaga, Anton, Laird, Dale W.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 09-06-2017; American Society for Biochemistry and Molecular Biology
• Subjects: Amino Acid Substitution; Cell Death - genetics; connexin; Connexin 30; Connexin 43 - genetics; Connexin 43 - metabolism; Connexins - genetics; Connexins - metabolism; connexon (hemichannel); gap junction; Gap Junctions - genetics; Gap Junctions - metabolism; Hearing Loss - genetics; Hearing Loss - metabolism; HeLa Cells; Humans; Keratinocytes - metabolism; Molecular Bases of Disease; mutant; Mutation, Missense; skin; Skin Diseases, Genetic - genetics; Skin Diseases, Genetic - metabolism; skin; gap junction; connexon (hemichannel); mutant; connexin
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.M116.770917

Connexin26 (Cx26) is a gap junction protein that oligomerizes in the cell to form hexameric transmembrane channels called connexons. Cell surface connexons dock between adjacent cells to allow for gap junctional intercellular communication. Numerous autosomal dominant mutations in the Cx26-encoding GJB2 gene lead to many skin disorders and sensorineural hearing loss. Although some insights have been gained into the pathogenesis of these diseases, it is not fully understood how distinct GJB2 mutations result in hearing loss alone or in skin pathologies with comorbid hearing loss. Here we investigated five autosomal dominant Cx26 mutants (N14K, D50N, N54K, M163V, and S183F) linked to various syndromic or nonsyndromic diseases to uncover the molecular mechanisms underpinning these disease links. We demonstrated that when gap junction-deficient HeLa cells expressed the N14K and D50N mutants, they undergo cell death. The N54K mutant was retained primarily within intracellular compartments and displayed dominant or transdominant properties on wild-type Cx26 and coexpressed Cx30 and Cx43. The S183F mutant formed some gap junction plaques but was largely retained within the cell and exhibited only a mild transdominant reduction in gap junction communication when co-expressed with Cx30. The M163V mutant, which causes only hearing loss, exhibited impaired gap junction function and showed no transdominant interactions. These findings suggest that Cx26 mutants that promote cell death or exert transdominant effects on other connexins in keratinocytes will lead to skin diseases and hearing loss, whereas mutants having reduced channel function but exhibiting no aberrant effects on coexpressed connexins cause only hearing loss. Moreover, cell death-inducing GJB2 mutations lead to more severe syndromic disease.